MSTR vs SRPT · rev $477.2M vs rev $1.90B
MicroStrategy Incorporated (MSTR) versus Sarepta Therapeutics Inc (SRPT) — a side-by-side from cached financials, not a winner call.
MicroStrategy Incorporated (MSTR) is a software - application company listed on US.
Sarepta Therapeutics Inc (SRPT) is a biotechnology company listed on US.
Latest reported MSTR revenue for 2025-12-31 was $477.2M. Net income was -$3.85B. Revenue was up 3.0% from 2024-12-31 to 2025-12-31. MSTR currently screens at market cap $52.71B.
Latest reported SRPT revenue for 2024-12-31 was $1.90B. Net income was $235.2M. Revenue was up 53.0% from 2023-12-31 to 2024-12-31. SRPT currently screens at market cap $2.34B.
MSTR currently screens at market cap $52.71B. SRPT currently screens at market cap $2.34B.
Not investment advice. Open the MSTR and SRPT stock pages for the full models.
Not investment advice.